LIVE

Serial Number

90857980

Owner

SAREPTA THERAPEUTICS, INC.

Attorney

Maury M. Tepper, III

First Use Date

Feb 19, 2020

Filing Date

Jul 30, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

EXONDYS 51 (ETEPLIRSEN) Trademark

Serial Number: 90857980 • Registration: 7032061

EXONDYS 51 (ETEPLIRSEN) is a trademark filed by SAREPTA THERAPEUTICS, INC. on July 30, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

SAREPTA THERAPEUTICS, INC. (109 trademarks)

215 FIRST STREET, SUITE 7
CAMBRIDGE, MA 02142

Entity Type: 03

Legal Representation

Attorney of Record

Maury M. Tepper, III

5,860 trademarks filed View all →

Trademark Details

Filing Date

July 30, 2021

Registration Date

April 18, 2023

First Use Anywhere

February 19, 2020

First Use in Commerce

February 19, 2020

Published for Opposition

March 22, 2022

Goods & Services

Pharmaceutical preparations featuring antisense oligonucleotides for the treatment of neuromuscular diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 18, 2023 NRCC

REGISTERED-PRINCIPAL REGISTER

Apr 18, 2023 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 14, 2023 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 12, 2023 CNPR

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 21, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 21, 2023 CRFA

ASSIGNED TO LIE

Feb 21, 2023 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 15, 2022 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 12, 2022 GNRN

NON-FINAL ACTION E-MAILED

Dec 12, 2022 GNRT

SU - NON-FINAL ACTION - WRITTEN

Dec 12, 2022 CNRT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 24, 2022 EXRA

STATEMENT OF USE PROCESSING COMPLETE

Nov 23, 2022 SUPC

SOU EXTENSION 1 GRANTED

Nov 23, 2022 EX1G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 23, 2022 AITU

USE AMENDMENT FILED

Nov 12, 2022 IUAF

SOU EXTENSION 1 FILED

Nov 12, 2022 EXT1

SOU TEAS EXTENSION RECEIVED

Nov 12, 2022 EEXT

TEAS STATEMENT OF USE RECEIVED

Nov 12, 2022 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 17, 2022 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 22, 2022 NPUB

PUBLISHED FOR OPPOSITION

Mar 22, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 2, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 14, 2022 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 11, 2022 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 11, 2022 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 11, 2022 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 9, 2022 GNRN

NON-FINAL ACTION E-MAILED

Feb 9, 2022 GNRT

NON-FINAL ACTION WRITTEN

Feb 9, 2022 CNRT

EXAMINER'S AMENDMENT ENTERED

Feb 7, 2022 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 7, 2022 GNEN

EXAMINERS AMENDMENT E-MAILED

Feb 7, 2022 GNEA

EXAMINERS AMENDMENT -WRITTEN

Feb 7, 2022 CNEA

ASSIGNED TO EXAMINER

Feb 2, 2022 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Sep 28, 2021 MDSM

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 27, 2021 NWOS

NEW APPLICATION ENTERED

Aug 3, 2021 NWAP

Related Trademarks

More from this Owner

ELYMBI

BETRUVO

MYOPEPDYS (VESLETEPLIRSEN) INJECTION

More in Same Class

YORUN

TR TINARUNY